Prev:Crosstalk between 5-methylcytosine and N6-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic …(BMU101-EN-37.3)
Next:Clinical, genetic, and molecular characteristics in a central‐southern Chinese cohort of genetic leukodystrophies(A23210-5.3)